KLP Kapitalforvaltning AS Makes New $109,000 Investment in Grail, Inc. (NASDAQ:GRAL)

KLP Kapitalforvaltning AS purchased a new stake in shares of Grail, Inc. (NASDAQ:GRAL) during the fourth quarter, HoldingsChannel reports. The fund purchased 6,100 shares of the company’s stock, valued at approximately $109,000.

Several other large investors have also made changes to their positions in the business. Douglas Lane & Associates LLC bought a new stake in Grail during the 4th quarter valued at approximately $3,034,000. A. D. Beadell Investment Counsel Inc. purchased a new stake in Grail during the 4th quarter valued at approximately $430,000. FNY Investment Advisers LLC bought a new stake in shares of Grail during the fourth quarter valued at approximately $26,000. 180 Wealth Advisors LLC purchased a new position in shares of Grail in the fourth quarter worth $1,681,000. Finally, B & T Capital Management DBA Alpha Capital Management purchased a new position in shares of Grail in the fourth quarter worth $387,000.

Insider Buying and Selling at Grail

In other Grail news, CFO Aaron Freidin sold 1,816 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.20, for a total transaction of $56,659.20. Following the sale, the chief financial officer now directly owns 335,170 shares of the company’s stock, valued at $10,457,304. The trade was a 0.54 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, President Joshua J. Ofman sold 2,109 shares of the firm’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $65,800.80. Following the completion of the sale, the president now directly owns 559,673 shares of the company’s stock, valued at $17,461,797.60. The trade was a 0.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 11,550 shares of company stock worth $360,436 over the last 90 days.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley raised their target price on shares of Grail from $16.00 to $20.00 and gave the company an “equal weight” rating in a research note on Tuesday, March 18th.

Grail Trading Down 8.6 %

NASDAQ:GRAL opened at $22.75 on Friday. The business’s 50-day moving average is $33.62 and its 200 day moving average is $23.13. Grail, Inc. has a 12 month low of $12.33 and a 12 month high of $63.99.

Grail (NASDAQ:GRAL) last issued its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, topping the consensus estimate of ($4.41) by $2.55. The firm had revenue of $38.25 million for the quarter, compared to analysts’ expectations of $35.33 million. On average, equities analysts predict that Grail, Inc. will post -15.15 earnings per share for the current fiscal year.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.